<VariationArchive RecordType="classified" VariationID="10856" VariationName="NM_000276.4(OCRL):c.2470_2581del (p.Val824Leufs*9)" VariationType="Deletion" Accession="VCV000010856" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2020-03-01" MostRecentSubmission="2020-03-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25895" VariationID="10856">
      <GeneList>
        <Gene Symbol="OCRL" FullName="OCRL inositol polyphosphate-5-phosphatase" GeneID="4952" HGNC_ID="HGNC:8108" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xq26.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="129540259" stop="129592556" display_start="129540259" display_stop="129592556" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="128674251" stop="128726532" display_start="128674251" display_stop="128726532" Strand="+" />
          </Location>
          <OMIM>300535</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OCRL">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OCRL">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000276.4(OCRL):c.2470_2581del (p.Val824Leufs*9)</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.1</CytogeneticLocation>
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.128723824_128723935del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.128723824_128723935del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.129589847_129589958del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.129589847_129589958del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008638.1" sequenceAccession="NG_008638" sequenceVersion="1" change="g.54573_54684del">
            <Expression>NG_008638.1:g.54573_54684del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318784.2" sequenceAccession="NM_001318784" sequenceVersion="2" change="c.2475_2584+2del">
            <Expression>NM_001318784.2:c.2475_2584+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000276.4" sequenceAccession="NM_000276" sequenceVersion="4" change="c.2472_2581+2del" MANESelect="true">
            <Expression>NM_000276.4:c.2472_2581+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001587.4" sequenceAccession="NM_001587" sequenceVersion="4" change="c.2448_2557+2del">
            <Expression>NM_001587.4:c.2448_2557+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000276.4" sequenceAccession="NM_000276" sequenceVersion="4" change="c.2470_2581del" MANESelect="true">
            <Expression>NM_000276.4:c.2470_2581del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300535.0001" DB="OMIM" />
        <XRef Type="rs" ID="2124430398" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">The genomic location for this variant will not be computed from alignment of the transcript sequence to the genome until there is experimental evidence for the genomic basis of the loss of exon 23.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000276.4(OCRL):c.2470_2581del (p.Val824Leufs*9) AND Lowe syndrome" Accession="RCV000011603" Version="10">
        <ClassifiedConditionList TraitSetID="3031">
          <ClassifiedCondition DB="MedGen" ID="C0028860">Lowe syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1993-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1993-04-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-03-01" MostRecentSubmission="2020-03-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Leahey, A. M., Olivos, I. M., Bailey, L. C., Nussbaum, R. L. Characterization of the molecular defects in Lowe's syndrome. (Abstract) Am. J. Hum. Genet. 51 (suppl.): A220-only, 1992.</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8504307</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3031" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2569" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Oculocerebrorenal Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lowe oculocerebrorenal syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Lowe syndrome</ElementValue>
                <XRef ID="Lowe+oculocerebrorenal+syndrome/4314" DB="Genetic Alliance" />
                <XRef ID="79385002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Phosphatidylinositol 4,5-bisphosphate 5-phosphatase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OCRL1</ElementValue>
                <XRef Type="MIM" ID="309000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">OCRL</ElementValue>
                <XRef Type="MIM" ID="309000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3295" />
                <XRef ID="3295" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Lowe syndrome (oculocerebrorenal syndrome) is characterized by involvement of the eyes, central nervous system, and kidneys. Dense congenital cataracts are found in all affected boys and infantile glaucoma in approximately 50%. All boys have impaired vision; corrected acuity is rarely better than 20/100. Generalized hypotonia is noted at birth and is of central (brain) origin. Deep tendon reflexes are usually absent. Hypotonia may slowly improve with age, but normal motor tone and strength are never achieved. Motor milestones are delayed. Almost all affected males have some degree of intellectual disability; 10%-25% function in the low-normal or borderline range, approximately 25% in the mild-to-moderate range, and 50%-65% in the severe-to-profound range of intellectual disability. Affected males have varying degrees of proximal renal tubular dysfunction of the Fanconi type, including low molecular-weight (LMW) proteinuria, aminoaciduria, bicarbonate wasting and renal tubular acidosis, phosphaturia with hypophosphatemia and renal rickets, hypercalciuria, sodium and potassium wasting, and polyuria. The features of symptomatic Fanconi syndrome do not usually become manifest until after the first few months of life, except for LMW proteinuria. Glomerulosclerosis associated with chronic tubular injury usually results in slowly progressive chronic renal failure and end-stage renal disease between the second and fourth decades of life.</Attribute>
                <XRef ID="NBK1480" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301653</ID>
                <ID Source="BookShelf">NBK1480</ID>
              </Citation>
              <XRef ID="534" DB="Orphanet" />
              <XRef ID="C0028860" DB="MedGen" />
              <XRef ID="MONDO:0010645" DB="MONDO" />
              <XRef Type="MIM" ID="309000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31835" SubmissionDate="2020-02-27" DateLastUpdated="2020-03-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300535.0001_LOWE OCULOCEREBRORENAL SYNDROME" title="OCRL, 112-BP DEL_LOWE OCULOCEREBRORENAL SYNDROME" />
        <ClinVarAccession Accession="SCV000031835" DateUpdated="2020-03-01" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1993-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with Lowe syndrome (309000), Leahey et al. (1992, 1993) demonstrated an 112-bp deletion (nucleotides 2686-2797) in the OCRL cDNA, resulting in a frameshift and a premature termination 9 codons downstream, where CGA (arg) was converted to UGA (ter). They used single-strand conformation polymorphism (SSCP) analysis followed by sequencing to identify the mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">8504307</ID>
              </Citation>
              <Citation>
                <CitationText>Leahey, A. M., Olivos, I. M., Bailey, L. C., Nussbaum, R. L. Characterization of the molecular defects in Lowe's syndrome. (Abstract) Am. J. Hum. Genet. 51 (suppl.): A220-only, 1992.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="309000" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCRL" />
          </GeneList>
          <Name>OCRL, 112-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">112-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300535.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LOWE OCULOCEREBRORENAL SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="31835" TraitType="Disease" MappingType="Name" MappingValue="LOWE OCULOCEREBRORENAL SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0028860" Name="Lowe syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

